Randomised clinical trial: vercirnon, an oral CCR9 antagonist,vs. placebo as induction therapy in active Crohn’s disease
Randomised clinical trial: vercirnon, an oral CCR9 antagonist,vs. placebo as induction therapy in active Crohn’s disease
Efficacy of mesalazine or beclomethasone dipropionate enema or their combination in patients with distal active ulcerative colitis
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease